News for IDEAYA Biosciences, Inc. (IDYA)

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiat...

Summary IDEAYA Biosciences Inc (IDYA), a precision medicine oncology company, announced on June 27, 2025, that its Compensation Committee has granted non-qualif

On June 26, 2025, IDEAYA Biosciences (IDYA), a company listed on the NASDAQ, saw new analyst coverage initiated by Wells Fargo. Renowned analyst Eva Fortea Verd

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiat...

On June 9, 2025, Logos Global Management LP (Trades, Portfolio) executed a significant transaction by acquiring 4,800,000 shares of Arvinas Inc at a price of $7

Summary IDEAYA Biosciences Inc (IDYA), a leader in precision medicine oncology, announced on June 2, 2025, its participation in two significant investor relatio

PR NewswireSOUTH SAN FRANCISCO, Calif., June 2, 2025 SOUTH SAN FRANCISCO, Calif., June 2, 2025 /PRNewswire/ -- IDEAYA Biosciences, Inc. (NASDAQ: IDYA), a p

IDEAYA Biosciences (IDYA) to participate in key healthcare investor conferences in June 2025. Live webcasts of the events will be available, with replay

Summary IDEAYA Biosciences Inc (IDYA), a precision medicine oncology company, announced on May 30, 2025, that its Compensation Committee has granted non-qualifi

PR NewswireSOUTH SAN FRANCISCO, Calif., May 30, 2025 SOUTH SAN FRANCISCO, Calif., May 30, 2025 /PRNewswire/ -- IDEAYA Biosciences, Inc. (NASDAQ: IDYA), a p

On May 29, 2025, IDEAYA Biosciences (IDYA) disclosed that its Board of Directors' Compensation Committee has awarded non-qualified stock options to purchase a t

PR NewswireAUSTIN, Texas, May 8, 2025 Announces Intention to Withhold Votes for Directors Dr. Mary Ann Gray and Dr. Alpna SethAUSTIN, Texas, May 8, 2025 /P

PR NewswireSOUTH SAN FRANCISCO, Calif., May 6, 2025 ~$1.05 billion of cash, cash equivalents and marketable securities as of March 31, 2025, and an updated

We recently published a list of Top 11 Small Cap Stocks to Buy with Biggest Upside Potential. In this article, we are going to take a look at where IDEAYA Biosciences, Inc. (NASDAQ:IDYA) stands against other top small cap stocks to buy with biggest upside potential. On April 24, Jill Carey Hall, BofA Securities head […]

We recently published a list of Top 11 Small Cap Stocks to Buy with Biggest Upside Potential. In this article, we are going to take a look at where IDEAYA Biosciences, Inc.

PR NewswireTHOUSAND OAKS, Calif., May 1, 2025 THOUSAND OAKS, Calif., May 1, 2025 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced financial results for

Summary IDEAYA Biosciences Inc (IDYA), a precision medicine oncology company, announced on April 28, 2025, its participation in upcoming investor relations even

IDEAYA Biosciences (IDYA) will participate in two major investor relations events in May 2025. CEO Yujiro S. Hata will feature in fireside chats at both

PR NewswireSOUTH SAN FRANCISCO, Calif., April 25, 2025 SOUTH SAN FRANCISCO, Calif., April 25, 2025 /PRNewswire/ -- IDEAYA Biosciences, Inc. (NASDAQ: IDYA),